Publications by authors named "Solveig Ericson"

Claim this Profile
I
Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy.
Stacie Ittershagen, Solveig Ericson, Lamis Eldjerou, Ali Shojaee, Eric Bleickardt

Curr Hematol Malig Rep· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building blocks for institutional preparation of CTL019 delivery.
Joseph McGuirk, Edmund K Waller, Muna Qayed, Sunil Abhyankar, Solveig Ericson

Cytotherapy· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib.
Sikander Ailawadhi, Luke P Akard, Carole B Miller, Anand Jillella, Daniel J DeAngelo, Solveig G Ericson

Ther Adv Hematol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Marker-Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK Study.
Noopur Raje, Robert Vescio, Charles W Montgomery, Ashraf Badros, Nikhil Munshi, Solveig G Ericson

Clin Cancer Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gleevec High-Dose Therapy study.
Luke P Akard, Jorge E Cortes, Maher Albitar, Stuart L Goldberg, Ghulam Warsi, Solveig G Ericson

Arch Pathol Lab Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of treatment and monitoring patterns and subsequent outcomes among patients with chronic myeloid leukemia treated with imatinib in a community setting.
Mansoor N Saleh, Sally Haislip, Joyce Sharpe, Tamara Hess, James Gilmore, Solveig G Ericson

Curr Med Res Opin· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib.
Stuart L Goldberg, Lei Chen, Annie Guerin, Alexander R Macalalad, Nathan Liu, Solveig G Ericson

Curr Med Res Opin· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring and switching patterns of patients with chronic myeloid leukemia treated with imatinib in community settings: a chart review analysis.
Lei Chen, Annie Guérin, Jipan Xie, Eric Q Wu, Andrew P Yu, Solveig G Ericson

Curr Med Res Opin· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole.
Adam M Brufsky, W Graydon Harker, J Thaddeus Beck, Linda Bosserman, Charles Vogel, Solveig G Ericson

Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of skeletal complications and treatment patterns associated with early vs. delayed zoledronic acid therapy in multiple myeloma.
Eric Q Wu, Arielle G Bensimon, Maryna Marynchenko, Madhav Namjoshi, Amy Guo, Solveig G Ericson

Clin Lymphoma Myeloma Leuk· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a multicenter open-label randomized trial evaluating infusion duration of zoledronic acid in multiple myeloma patients (the ZMAX trial).
James R Berenson, Ralph Boccia, Timothy Lopez, Ghulam M Warsi, Eliza Argonza-Aviles, Solveig G Ericson

J Support Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer.
Kishan J Pandya, Ajeet Gajra, Ghulam M Warsi, Eliza Argonza-Aviles, Solveig G Ericson

Lung Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA drug information that never reaches clinicians.
John Hohneker, Solveig Ericson, Gabriela Gruia

N Engl J Med· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results.
Adam M Brufsky, Linda D Bosserman, Richard R Caradonna, Barbara B Haley, C Michael Jones, Solveig G Ericson

Clin Breast Cancer· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.
Adam Brufsky, Nigel Bundred, Robert Coleman, Rosemary Lambert-Falls, Raul Mena, Solveig Ericson

Oncologist· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclosporin a and tacrolimus (FK506) differentially alter T-cell receptor expression in vivo.
Jamie Leigh Miller, Solveig Gronning Ericson

Immunopharmacol Immunotoxicol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit.
Sobha Kurian, Muzzafar Qazilbash, Joseph Fay, S Wolff, Roger Herzig, Solveig Ericson

Breast J· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An improved methodology to detect human T cell receptor beta variable family gene expression patterns.
Jamie Leigh Brewer, Solveig Gronning Ericson

J Immunol Methods· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vanadate stimulates monocytic differentiation activity of IL-6 by enhancing actin filament polymerization in HL-60 cells.
Yuan Yao, Qun Zhou, Solveig G Ericson

J Biomed Sci· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired Robertsonian translocations in leukemia: two more cases.
Daniel B Herring, Kerry A Harbert, Sharon L Wenger, Solveig G Ericson

Cancer Genet Cytogenet· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy and autologous stem cell transplantation in relapsed and refractory Hodgkin's disease: outcome based on a prognostic model.
Muzaffar H Qazilbash, Marcel P Devetten, Jame Abraham, Joseph P Lynch, Charles L Beall, Solveig G Ericson

Acta Haematol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The protein tyrosine phosphatase CD45 is required for interleukin 6 signaling in U266 myeloma cells.
Qun Zhou, Yuan Yao, Solveig G Ericson

Int J Hematol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Chromosome Abnormalities Following Bone Marrow Transplant for Chronic Myelogenous Leukemia.
Xi Wang, Ifti Ahmed, Solveig Ericson, Sharon Wenger

J Assoc Genet Technol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of a prognostic scoring system for allogeneic stem cell transplantation in patients with chronic myeloid leukemia.
Muzaffar H Qazilbash, Marcel P Devetten, Jame Abraham, Joseph P Lynch, Charles L Beall, Solveig G Ericson

Acta Haematol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis